Molina Healthcare Shares Plunge After Disappointing Q4 Earnings and 2026 Guidance
Molina Healthcare's stock fell 31.69% in pre-market trading, hitting a 52-week low, following a disappointing earnings report and guidance for 2026.
The company's Q4 earnings revealed a significant loss of $2.75 per share, missing expectations, and it projected adjusted earnings of only $5.00 per share for 2026, far below the consensus of $13.71. Additionally, Molina's revenue forecast for 2026 was downgraded to $44.5 billion, below market expectations, primarily due to challenges associated with a new Medicaid contract and a strategic shift away from its Medicare Advantage Part D plan.
This sharp decline in stock price reflects strong investor disappointment and concerns about Molina's future profitability and strategic direction, which may lead to increased volatility in the short term.
Trade with 70% Backtested Accuracy
Analyst Views on MOH
About MOH
About the author

- Lawsuit Survives: The securities fraud class action against Five9 has survived a motion to dismiss in federal court, indicating that plaintiffs allege executives failed to disclose underperformance, potentially leading to financial losses for shareholders.
- Misrepresentation of Performance: Plaintiffs claim that Five9 executives falsely represented the strength of new business bookings during the first half of 2024, forcing the company to cut its annual revenue guidance, which negatively impacts investor confidence.
- Shareholder Actions: Shareholders holding Five9 stock can seek corporate reforms and fund returns, reflecting a strong demand for improved governance and transparency, which may prompt the company to adopt stricter compliance measures.
- Legal Consequences: The progress of this case could negatively affect Five9's stock price, necessitating investor attention on subsequent legal proceedings and their potential impact on the company's operations.
- Earnings Release Schedule: Molina Healthcare will issue its Q1 2026 earnings release after market close on April 22, 2026, providing critical financial data that could influence investor confidence and stock performance.
- Conference Call Details: The company will host a conference call on April 23, 2026, at 8:00 a.m. Eastern Time, accessible by dialing (877) 883-0383 with confirmation number 4352622, aimed at discussing the earnings report and addressing investor inquiries.
- Replay Availability: A telephonic replay of the conference call will be available until April 30, 2026, allowing investors who missed the live event to access important information by calling (855) 669-9658, ensuring broader communication of key insights.
- Investor Day Announcement: Molina Healthcare will also host its Investor Day on May 8, 2026, with a live webcast available on the company's investor relations website, enhancing engagement and transparency with investors regarding future strategies.
- Energy Sector Decline: As of midday Tuesday, energy companies are down 0.4%, with ONEOK Inc (OKE) and EQT Corp (EQT) showing losses of 5.2% and 1.7%, respectively, indicating sector weakness that may impact investor confidence.
- ETF Performance Analysis: The Energy Select Sector SPDR ETF (XLE) is down 0.2% on the day but up 23.09% year-to-date, suggesting that despite short-term volatility, the long-term trend remains positive, potentially attracting more investor interest.
- Healthcare Sector Weakness: The healthcare sector is up 0.3% overall, yet Molina Healthcare Inc (MOH) and CVS Health Corporation (CVS) are down 4.2% and 3.7%, respectively, reflecting challenges faced by the sector that may influence future investment decisions.
- ETF Tracking Status: The Health Care Select Sector SPDR ETF (XLV) is down 0.3% on the day and up 2.09% year-to-date, showing some resilience despite short-term underperformance, which may provide investors with opportunities for risk diversification.
- Shareholder Investigation Initiated: Grabar Law Office is investigating Integer Holdings Corp. (NYSE: ITGR) for potential breaches of fiduciary duties by its executives, allowing shareholders who purchased before July 25, 2024, to seek corporate reforms and fund recovery.
- False Statements Allegations: A recent federal securities fraud class action claims that Integer failed to disclose its true competitive position in the EP manufacturing market, misleading investors about the company's business prospects and undermining investor confidence.
- Similar Issues for Molina Healthcare: Molina Healthcare, Inc. (NYSE: MOH) is also under investigation by Grabar Law Office for failing to disclose adverse information regarding medical cost trends, which could lead to significant cuts in financial guidance for fiscal year 2025.
- Varonis Systems Faces Major Losses: Varonis Systems, Inc. (NASDAQ: VRNS) is being investigated for not accurately disclosing its expected annual recurring revenue (ARR), resulting in a significant miss in its third-quarter results and a stock price drop of over 48% in a single day.
- New Investment Position: Baupost Group established a new stake in Amazon during Q4, making it the fund's second-largest holding at 9.3% of assets, reflecting confidence in the e-commerce and cloud giant despite differing views from Buffett.
- Portfolio Adjustments: The fund completely exited its position in PagSeguro Digital in Q4, indicating a strategic portfolio adjustment likely based on market performance and future expectations.
- Top Holdings: As of December 31, Restaurant Brands International remains Baupost's largest holding, indicating sustained confidence in the restaurant sector, and it was also the top holding in Q3, showcasing stability.
- Market Performance Comparison: Amazon was the worst-performing stock among the Magnificent Seven in 2025, and Baupost's investment decision may be based on optimism regarding its cloud segment growth, which will test the effectiveness of Klarman's strategy against Buffett's reduction in exposure.
- New Investment Position: Baupost Group established a new position in Amazon worth $489.7 million in Q4, making it the firm's second-largest holding, despite the stock's 13% decline year-to-date amid tech sector struggles.
- Market Environment Challenges: Amazon is over 22% off its recent high and entered a bear market last week, reflecting concerns about the tech sector's high valuations and its ability to deliver on lofty AI promises.
- Value Investor Dilemma: Klarman, a value investor, has faced challenges over the past decade, particularly in a low-interest-rate environment where growth stocks dominated the market, although many analysts remain bullish on Amazon, believing its higher spending is justified.
- Other Investment Moves: Baupost also took new stakes in Grupo Aeromexico and Molina Healthcare, both of which are down over 12% and 21% year-to-date, respectively, while reducing its allocation to Restaurant Brands International and Alphabet.








